Donghui Lu

机构：Anhui Medical University, Environmental Protection Engineering (Greece), Peking University Shenzhen Hospital, 181st Hospital of Chinese People's Liberation Army, First Affiliated Hospital of Anhui Medical University · ORCID：0009-0000-9692-4045

发表论文 37 篇 · 总被引 241 次 · h-index 8

代表论文

• Endoplasmic reticulum stress promotes sorafenib resistance via miR-188-5p/hnRNPA2B1-mediated upregulation of PKM2 in hepatocellular carcinoma (2021 · Molecular Therapy — Nucleic Acids · 被引 51)
• A comparison between three‐dimensional conformal radiotherapy combined with interventional treatment and interventional treatment alone for hepatocellular carcinoma with portal vein tumour thrombosis (2014 · Journal of Medical Imaging and Radiation Oncology · 被引 27)
• COX-2 induces apoptosis-resistance in hepatocellular carcinoma cells via the HIF-1α/PKM2 pathway (2018 · International Journal of Molecular Medicine · 被引 26)
• Effectiveness and safety of low‐dose apatinib in advanced gastric cancer: A real‐world study (2020 · Cancer Medicine · 被引 24)
• Peptostreptococcus Anaerobius enhances dextran sulfate sodium-induced colitis by promoting nf-κB-NLRP3-Dependent macrophage pyroptosis (2024 · Virulence · 被引 21)
• High PKM2 expression is independently correlated with decreased overall survival in hepatocellular carcinoma (2018 · Oncology Letters · 被引 21)